Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-01-30Clinical Trial Update: Evaluating Safety and Efficacy In Hepatitis C Patients After PegIntron Pen Treatment (Study P04896)
This terminated clinical trial (P04896) evaluated the safety and efficacy of PegIntron Pen in chronic hepatitis C patients, with results pos…
-
CLINICAL_TRIALS trial_result · 2012-01-30Clinical Trial Update: Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED) [Phase 4]
A Phase 4 trial evaluating PegIntron plus ribavirin for chronic hepatitis C in HIV-infected subjects was terminated, with results posted in …
-
CLINICAL_TRIALS trial_result · 2012-01-24Clinical Trial Update: Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects [Phase 1]
Phase 1 clinical trial update of ABT-267 in healthy volunteers and Hepatitis C virus infection (genotype 1) has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED) [Phase 4]
A Phase 4 trial evaluating pegylated interferon alfa-2b in combination with low-dose ribavirin for chronic hepatitis C genotype 1 patients w…
-
CLINICAL_TRIALS trial_result · 2011-12-30Clinical Trial Update: Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4 [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating retreatment with high-dose pegylated interferon alfa-2a and ribavirin in previous nonrespond…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-29Clinical Trial Update: Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED) [Phase 2]
This Phase 2 study evaluated boceprevir in combination with pegylated interferon alfa-2b, with or without added ribavirin, in patients with …
-
CLINICAL_TRIALS trial_result · 2011-12-15Clinical Trial Update: Role of FXR in Hepatitis C Virus Replication [NA]
The clinical trial investigating the role of FXR in Hepatitis C virus replication has been terminated; no results are provided in this updat…
-
CLINICAL_TRIALS trial_result · 2011-12-14Clinical Trial Update: Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease
A completed clinical trial comparing selenium levels in patients with hepatitis C at various disease stages, including liver cirrhosis and h…
-
CLINICAL_TRIALS trial_result · 2011-12-09Clinical Trial Update: Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection [Phase 2]
Phase 2 study of FK788 in chronic hepatitis C has completed; no results are provided in the summary.
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation [Phase 4]
Phase 4 trial evaluating cyclosporine for viral clearance in hepatitis C after liver transplantation has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-12-05Clinical Trial Update: Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection [Phase 2]
Phase 2 trial update on PEG-rIL-29 plus ribavirin for chronic hepatitis C infection, focusing on efficacy and safety. The current status is …
-
CLINICAL_TRIALS trial_result · 2011-12-02Clinical Trial Update: Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of peginterferon alfa-2b plus ribavirin in subjects with Hepatitis C and compensated liver …
-
CLINICAL_TRIALS trial_result · 2011-11-28Clinical Trial Update: ATHENAS - Retrospective Study of Compliance in Chronic Hepatitis C With Pegylated Interferon Alfa-2b/Ribavirin in Brazil (P05632)
Retrospective study examining patient compliance with pegylated interferon alfa-2b plus ribavirin for chronic hepatitis C in Brazil; the ATH…
-
CLINICAL_TRIALS trial_result · 2011-11-21Clinical Trial Update: Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects [Phase 1]
A Phase 1 study assessing safety, tolerability, pharmacokinetics, and antiviral activity of JTK-853 in Hepatitis C genotype 1–infected subje…
-
CLINICAL_TRIALS trial_result · 2011-11-18Clinical Trial Update: Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690)
A completed clinical trial (P04690) provides an update on patient compliance during pegylated interferon alfa-2b plus ribavirin therapy for …
-
CLINICAL_TRIALS trial_result · 2011-11-11Clinical Trial Update: High Dose Ribavirin in the Treatment of Chronic Hepatitis C [Phase 2]
A completed Phase 2 clinical trial evaluating high-dose ribavirin for chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2011-11-11Clinical Trial Update: Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C [Phase 4]
A Phase 4 clinical trial assessing safety and effectiveness of Pegasys (pegylated interferon alfa-2a) and Copegus (ribavirin) in liver trans…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209)
Clinical trial update (NCT00724464) evaluating PegIntron (peginterferon alfa-2b) plus Rebetol (ribavirin) in treatment-naïve adults with chr…
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C [Phase 3]
Phase 3 trial evaluated the efficacy and safety of ursodeoxycholic acid for chronic hepatitis C; the study completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2011-10-28Clinical Trial Update: Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy
This clinical trial update reports that patterns of early decline in Hepatitis C virus RNA during interferon therapy may predict eventual tr…
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus [Phase 4]
Phase 4 trial comparing cyclosporine microemulsion versus tacrolimus in liver transplant recipients with Hepatitis C, assessing liver fibros…
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects [Phase 2]
An update on a Phase 2 clinical trial evaluating an oral anti-CD3 monoclonal antibody in non-responder patients with genotype I chronic hepa…
-
CLINICAL_TRIALS trial_result · 2011-10-21Clinical Trial Update: Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C
The trial results indicate that menopausal status significantly influences failure rates of antiviral therapy in women with chronic hepatiti…
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects [Phase 2]
This entry covers a Phase 2 clinical trial evaluating CHRONVAC-C followed by standard of care in adults with chronic Hepatitis C. The curren…
-
CLINICAL_TRIALS trial_result · 2011-10-07Clinical Trial Update: HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China
A completed clinical trial conducted in China investigated hepatitis C virus genotyping alongside host IL28B (Interleukin 28B) genotyping to…